Biametrics this week announced the availability of B-screen, its label-free microarray screening device, in European markets.
Tübingen, Germany-based Biametrics claimed the device enables the analysis of arrays in a standard microscope slide format, and that it could be used in applications such as bioanalytics, drug discovery, production, and quality control.
According to the company, B-screen provides a read out of up to 10,000 spots per cm. The system relies on an automated microfluidics device to incubate arrays with samples of interest, and can be used to assay serum, whole blood, cell culture, and other sample types. Biametrics said that B-screen can be used with multiple array layouts, glass or plastic substrates, and most array printers.